These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14623266)

  • 1. WAY-140312 reduces plasma PAI-1 while maintaining normal platelet aggregation.
    Crandall DL; Hennan JK; Elokdah H; Krishnamurthy G; Antrilli TM; Bauer JS; Morgan GA; Swillo RE
    Biochem Biophys Res Commun; 2003 Nov; 311(4):904-8. PubMed ID: 14623266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
    Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
    Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of PAI-1 and tPA activity and thrombolytic effects of corilagin.
    Shen ZQ; Dong ZJ; Peng H; Liu JK
    Planta Med; 2003 Dec; 69(12):1109-12. PubMed ID: 14750026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
    Crandall DL; Elokdah H; Di L; Hennan JK; Gorlatova NV; Lawrence DA
    J Thromb Haemost; 2004 Aug; 2(8):1422-8. PubMed ID: 15304050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low dose aspirin on augmented plasminogen activator inhibitor type 1 activity in patients with permanent pacemakers.
    Abe H; Takahara K; Nakashima Y; Kuroiwa A
    Pacing Clin Electrophysiol; 1994 Feb; 17(2):146-51. PubMed ID: 7513398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
    Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic activities of oroxylin A in vitro and in vivo.
    Ku SK; Lee IC; Bae JS
    Arch Pharm Res; 2014 May; 37(5):679-86. PubMed ID: 23963976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats.
    Yamagishi S; Matsui T; Nakamura K; Takenaka K
    Clin Exp Med; 2009 Mar; 9(1):73-6. PubMed ID: 18815870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1.
    Mousa SA; Forsythe MS; Bozarth JM; Reilly TM
    Cardiology; 1993; 83(5-6):367-73. PubMed ID: 8111770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
    Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
    Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro.
    Ku SK; Yoon EK; Lee W; Kwon S; Lee T; Bae JS
    Arch Pharm Res; 2016 Mar; 39(3):398-408. PubMed ID: 26762345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on fibrinolysis and platelet function].
    Deguchi K; Murashima S; Nishikawa M; Shirakawa S
    Nihon Rinsho; 1992 Feb; 50(2):297-302. PubMed ID: 1613983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.
    Eitzman DT; Fay WP; Lawrence DA; Francis-Chmura AM; Shore JD; Olson ST; Ginsburg D
    J Clin Invest; 1995 May; 95(5):2416-20. PubMed ID: 7738206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits.
    Friederich PW; Levi M; Biemond BJ; Charlton P; Templeton D; van Zonneveld AJ; Bevan P; Pannekoek H; ten Cate JW
    Circulation; 1997 Aug; 96(3):916-21. PubMed ID: 9264501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
    Rupin A; Gaertner R; Mennecier P; Richard I; Benoist A; De Nanteuil G; Verbeuren TJ
    Thromb Res; 2008; 122(2):265-70. PubMed ID: 18177924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3).
    Soni H; Jain M; Mehta AA
    Thromb Res; 2011 Jun; 127(6):551-9. PubMed ID: 21376373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss.
    Jankun J; Keck R; Selman SH; Skrzypczak-Jankun E
    Int J Mol Med; 2010 Oct; 26(4):501-4. PubMed ID: 20818488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tissue plasminogen activator/plasminogen activator inhibitor-1 by hydrocortisone in rat primary astrocytes.
    Kwon KJ; Cho KS; Lee SH; Kim JN; Joo SH; Ryu JH; Ignarro LJ; Han SH; Shin CY
    J Neurosci Res; 2011 Jul; 89(7):1059-69. PubMed ID: 21412817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis.
    Hennan JK; Morgan GA; Swillo RE; Antrilli TM; Mugford C; Vlasuk GP; Gardell SJ; Crandall DL
    J Thromb Haemost; 2008 Sep; 6(9):1558-64. PubMed ID: 18624980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.